NFKB1 and gastric cancer: While the IAA-AHR axis demonstrates pro-inflammatory effects (activating p38MAPK/NF-κB) in kidney diseases 38, this study reveals that it exerts anti-inflammatory effects in gastric cancer (inhibiting NF-κB via MTDH).